KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Gross Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -659.00
Dec 31, 2025 10,376.00
Sep 30, 2025 -3,223.00
Jun 30, 2025 2,314.00
Mar 31, 2025 -1,186.00
Dec 31, 2024 -1,294.00
Sep 30, 2024 1,813.00
Jun 30, 2024 -2,042.00
Mar 31, 2024 -135.00
Dec 31, 2023 -3,779.00
Sep 30, 2023 -2,026.00
Jun 30, 2023 -2,562.00
Mar 31, 2023 -2,812.00
Dec 31, 2022 -38,011.00
Sep 30, 2022 -1,843.00
Jun 30, 2022 -2,279.00
Mar 31, 2022 -587.00
Dec 31, 2021 6,656.00
Sep 30, 2021 -537.00
Jun 30, 2021 -590.00
Mar 31, 2021 -582.00
Dec 31, 2020 -8,352.00
Sep 30, 2020 1,873.00
Jun 30, 2020 -313.00
Mar 31, 2020 -336.00
Dec 31, 2019 156.00
Sep 30, 2019 307.00
Jun 30, 2019 369.00
Mar 31, 2019 33.00
Dec 31, 2018 -4,438.00
Sep 30, 2018 1,106.00
Jun 30, 2018 1,675.00
Mar 31, 2018 33.00
Dec 31, 2017 6,876.00
Sep 30, 2017 1,300.00
Jun 30, 2017 1,780.00
Mar 31, 2017 7.00
Dec 31, 2016 2,377.00
Sep 30, 2016 341.00
Jun 30, 2016 -372.00
Mar 31, 2016 -384.00
Dec 31, 2015 1,759.00
Sep 30, 2015 -313.00
Jun 30, 2015 -2,084.00
Mar 31, 2015 -2,117.00
Dec 31, 2014 -6,257.00
Sep 30, 2014 -744.00
Jun 30, 2014 -2,049.00
Mar 31, 2014 1,434.00